The FDA is aware that Dexcom has sent all affected customers an Urgent Medical Device Correction Notification for the Dexcom G7 Continuous Glucose Monitoring (CGM) App (for Android, iOS, and watchOS ...
The FDA has approved Signos, an AI-powered app that uses continuous glucose monitoring to guide weight loss and personalized nutrition. Cheaper than GLP-1 drugs, Signos offers real-time feedback on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback